Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Enhancing Drug Safety and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Enhancing Drug Safety and Innovation Act of 2007
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2007 · year_end · YY
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Source: Senate LDA
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Enhancing Drug Safety and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Enhancing Drug Safety and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Food and Drug Administration Amendments Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Food and Drug Administration Amendments Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Food and Drug Administration Amendments Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Food and Drug Administration Amendments Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Medicare Access to Rehabilitation Services Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
Medicare Access to Rehabilitation Services Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
Biologics Price Competition and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Biologics Price Competition and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Biologics Price Competition and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Biologics Price Competition and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Medicare Access to Rehabilitation Services Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
Medicare Access to Rehabilitation Services Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2007 · mid_year · MM
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE